Showing results (11-20 of 34) with videos related to
Sort By:
Pageof 4
Psychiatry Research|March 1, 1992
Plasma prolactin and homovanillic acid as markers for psychopathology and abnormal movements during maintenance haloperidol treatment in male patients with schizophreniaJ W Newcomer, S J Riney, S Vinogradov, et al.Psychopharmacology Bulletin|January 1, 1992
Plasma prolactin and homovanillic acid as markers for psychopathology and abnormal movements after neuroleptic dose decreaseJ W Newcomer, S J Riney, S Vinogradov, et al.The Journal of Clinical Endocrinology and Metabolism|November 5, 1997
Robust leptin secretory responses to dexamethasone in obese subjectsS Dagogo-Jack, G Selke, A K Melson, et al.Biological Psychiatry|August 25, 1991
Left-handedness in male schizophrenic patients is associated with increased impairment on the Luria-Nebraska Neuropsychological BatteryW O Faustman, J A Moses, D L Ringo, et al.Psychopharmacology Bulletin|January 1, 1991
Clinical factors that may confound the assessment of drug efficacyJ G Csernansky, J W Newcomer, L S Miller, et al.European Journal of Pharmacology|January 19, 1993
Subcortical excitatory amino acid levels after acute and subchronic administration of typical and atypical neurolepticsM E Bardgett, C T Wrona, J W Newcomer, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 1, 1994
Glucocorticoid-induced impairment in declarative memory performance in adult humansJ W Newcomer, S Craft, T Hershey, et al.Behavioral and Neural Biology|March 1, 1994
Chronic corticosterone treatment impairs spontaneous alternation behavior in ratsM E Bardgett, G T Taylor, J G Csernansky, et al.Psychopharmacology|January 1, 1993
Subcortical dopamine and serotonin turnover during acute and subchronic administration of typical and atypical neurolepticsJ G Csernansky, C T Wrona, M E Bardgett, et al.Biological Psychiatry|May 1, 1991
Symptomatology and cognitive impairment associate independently with post-dexamethasone cortisol concentrations in unmedicated schizophrenic patientsJ W Newcomer, W O Faustman, H A Whiteford, et al.Pageof 4